Scientists design new RNA therapy to bypass mutations behind thousands of genetic diseases
4 Articles
4 Articles
From cystic fibrosis to some forms of muscular dystrophy (ANSA)
A new RNA-based modified transfer therapy allows cells to dodge premature stop signs, restoring the production of essential proteins in pathologies such as cystic fibrosis or muscular dystrophy. The advancement developed at the University of Toronto has the potential to correct
University of Toronto - RNA breakthrough provides hope for thousands of untreatable diseases
Researchers at the University of Toronto have developed a next-generation RNA therapeutic approach with the potential to treat a wide range of genetic diseases that share certain disease-causing m. . .
Scientists design new RNA therapy to bypass mutations behind thousands of genetic diseases
A modified tRNA therapy bypassed premature genetic stop signals and restored working proteins in cystic fibrosis disease models. The post Scientists design new RNA therapy to bypass mutations behind thousands of genetic diseases appeared first on The Brighter Side of News.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium








